Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. [electronic resource] by
- Cho, Leslie
- Rocco, Michael
- Colquhoun, David
- Sullivan, David
- Rosenson, Robert S
- Dent, Ricardo
- Xue, Allen
- Scott, Rob
- Wasserman, Scott M
- Stroes, Erik
Producer: 20141110
In:
Clinical cardiology vol. 37
Availability: No items available.
|
|
9.
|
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study. [electronic resource] by
- Cho, Leslie
- Rocco, Michael
- Colquhoun, David
- Sullivan, David
- Rosenson, Robert S
- Dent, Ricardo
- Xue, Allen
- Scott, Rob
- Wasserman, Scott M
- Stroes, Erik
Producer: 20170713
In:
Cardiovascular drugs and therapy vol. 30
Availability: No items available.
|
|
10.
|
Stable predictive markers for Phytophthora sojae avirulence genes that impair infection of soybean uncovered by whole genome sequencing of 31 isolates. [electronic resource] by
- Arsenault-Labrecque, Geneviève
- Sonah, Humira
- Lebreton, Amandine
- Labbé, Caroline
- Marchand, Geneviève
- Xue, Allen
- Belzile, François
- Knaus, Brian J
- Grünwald, Niklaus J
- Bélanger, Richard R
Producer: 20190513
In:
BMC biology vol. 16
Availability: No items available.
|
|
11.
|
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab. [electronic resource] by
- Stroes, Erik
- Colquhoun, David
- Sullivan, David
- Civeira, Fernando
- Rosenson, Robert S
- Watts, Gerald F
- Bruckert, Eric
- Cho, Leslie
- Dent, Ricardo
- Knusel, Beat
- Xue, Allen
- Scott, Rob
- Wasserman, Scott M
- Rocco, Michael
Producer: 20140828
In:
Journal of the American College of Cardiology vol. 63
Availability: No items available.
|
|
12.
|
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. [electronic resource] by
- Raal, Frederick J
- Giugliano, Robert P
- Sabatine, Marc S
- Koren, Michael J
- Langslet, Gisle
- Bays, Harold
- Blom, Dirk
- Eriksson, Mats
- Dent, Ricardo
- Wasserman, Scott M
- Huang, Fannie
- Xue, Allen
- Albizem, Moetaz
- Scott, Rob
- Stein, Evan A
Producer: 20140522
In:
Journal of the American College of Cardiology vol. 63
Availability: No items available.
|
|
13.
|
Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma. [electronic resource] by
- Locke, Frederick L
- Neelapu, Sattva S
- Bartlett, Nancy L
- Siddiqi, Tanya
- Chavez, Julio C
- Hosing, Chitra M
- Ghobadi, Armin
- Budde, Lihua E
- Bot, Adrian
- Rossi, John M
- Jiang, Yizhou
- Xue, Allen X
- Elias, Meg
- Aycock, Jeff
- Wiezorek, Jeff
- Go, William Y
Producer: 20170606
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 25
Availability: No items available.
|
|
14.
|
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role. [electronic resource] by
- Raal, Frederick J
- Giugliano, Robert P
- Sabatine, Marc S
- Koren, Michael J
- Blom, Dirk
- Seidah, Nabil G
- Honarpour, Narimon
- Lira, Armando
- Xue, Allen
- Chiruvolu, Padmaja
- Jackson, Simon
- Di, Mei
- Peach, Matthew
- Somaratne, Ransi
- Wasserman, Scott M
- Scott, Rob
- Stein, Evan A
Producer: 20170825
In:
Journal of lipid research vol. 57
Availability: No items available.
|
|
15.
|
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. [electronic resource] by
- Nissen, Steven E
- Dent-Acosta, Ricardo E
- Rosenson, Robert S
- Stroes, Erik
- Sattar, Naveed
- Preiss, David
- Mancini, G B John
- Ballantyne, Christie M
- Catapano, Alberico
- Gouni-Berthold, Ioanna
- Stein, Evan A
- Xue, Allen
- Wasserman, Scott M
- Scott, Rob
- Thompson, Paul D
Producer: 20161219
In:
Clinical cardiology vol. 39
Availability: No items available.
|
|
16.
|
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. [electronic resource] by
- Brudno, Jennifer N
- Lam, Norris
- Vanasse, Danielle
- Shen, Yueh-Wei
- Rose, Jeremy J
- Rossi, John
- Xue, Allen
- Bot, Adrian
- Scholler, Nathalie
- Mikkilineni, Lekha
- Roschewski, Mark
- Dean, Robert
- Cachau, Raul
- Youkharibache, Philippe
- Patel, Rashmika
- Hansen, Brenna
- Stroncek, David F
- Rosenberg, Steven A
- Gress, Ronald E
- Kochenderfer, James N
Producer: 20200421
In:
Nature medicine vol. 26
Availability: No items available.
|
|
17.
|
Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma. [electronic resource] by
- Brudno, Jennifer N
- Lam, Norris
- Vanasse, Danielle
- Shen, Yueh-Wei
- Rose, Jeremy J
- Rossi, John
- Xue, Allen
- Bot, Adrian
- Scholler, Nathalie
- Mikkilineni, Lekha
- Roschewski, Mark
- Dean, Robert
- Cachau, Raul
- Youkharibache, Philippe
- Patel, Rashmika
- Hansen, Brenna
- Stroncek, David F
- Rosenberg, Steven A
- Gress, Ronald E
- Kochenderfer, James N
Publication details: Nature medicine 05 2020
In:
Nature medicine vol. 26
Availability: No items available.
|
|
18.
|
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels. [electronic resource] by
- Kochenderfer, James N
- Somerville, Robert P T
- Lu, Tangying
- Shi, Victoria
- Bot, Adrian
- Rossi, John
- Xue, Allen
- Goff, Stephanie L
- Yang, James C
- Sherry, Richard M
- Klebanoff, Christopher A
- Kammula, Udai S
- Sherman, Marika
- Perez, Arianne
- Yuan, Constance M
- Feldman, Tatyana
- Friedberg, Jonathan W
- Roschewski, Mark J
- Feldman, Steven A
- McIntyre, Lori
- Toomey, Mary Ann
- Rosenberg, Steven A
Producer: 20170913
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
19.
|
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. [electronic resource] by
- Locke, Frederick L
- Ghobadi, Armin
- Jacobson, Caron A
- Miklos, David B
- Lekakis, Lazaros J
- Oluwole, Olalekan O
- Lin, Yi
- Braunschweig, Ira
- Hill, Brian T
- Timmerman, John M
- Deol, Abhinav
- Reagan, Patrick M
- Stiff, Patrick
- Flinn, Ian W
- Farooq, Umar
- Goy, Andre
- McSweeney, Peter A
- Munoz, Javier
- Siddiqi, Tanya
- Chavez, Julio C
- Herrera, Alex F
- Bartlett, Nancy L
- Wiezorek, Jeffrey S
- Navale, Lynn
- Xue, Allen
- Jiang, Yizhou
- Bot, Adrian
- Rossi, John M
- Kim, Jenny J
- Go, William Y
- Neelapu, Sattva S
Producer: 20200416
In:
The Lancet. Oncology vol. 20
Availability: No items available.
|